Inogen (INGN) EBT Margin Growth (1y) (2014 - 2026)
Powered by 
Analysis
Inogen (INGN) EBT Margin Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -719.00 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 236.00 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 295.00 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 687.00 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 88.00 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 374.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -938.00 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 343.00 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 165.00 |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn | 45.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.00 |
| Mar 31, 2026 | -236.00 |
| Dec 31, 2025 | 359.00 |
| Sep 30, 2025 | 94.00 |
| Jun 30, 2025 | 164.00 |
| Mar 31, 2025 | 1,125.00 |
| Dec 31, 2024 | 2,309.00 |
| Sep 30, 2024 | 4,714.00 |
| Jun 30, 2024 | 539.00 |
| Mar 31, 2024 | 905.00 |
| Dec 31, 2023 | 2,972.00 |
| Sep 30, 2023 | -4,502.00 |
| Jun 30, 2023 | -844.00 |
| Mar 31, 2023 | -1,052.00 |
| Dec 31, 2022 | -5,640.00 |
| Sep 30, 2022 | -1,532.00 |
| Jun 30, 2022 | -1,508.00 |
| Mar 31, 2022 | -1,466.00 |
| Dec 31, 2021 | -198.00 |
| Sep 30, 2021 | 894.00 |